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Tumor necrosis factor (TNF)–related apoptosis-inducing ligand (TRAIL) is an apoptosis-inducing member of the 
TNF gene family which triggers apoptotic signals by interaction with its receptors. It has been suggested to be a 
major contributing factor to tissue degeneration. 
Objective 
The present study investigated, through immunohistochemistry, the regional expression of TRAIL and in 
temporomandibular joint (TMJ) disc of anterior disc displacement with reduction (ADDwR) and without 
reduction (ADDwoR) patients, to help determine the relationship between TMJ disc displacement and apoptosis. 
Study design 
We studied 18 TMJ diseased discs affected by disc displacement without or with reduction and 4 normal TMJ 
discs. Specimens were processed for immunohistochemistry to evaluate TRAIL and its receptor DR5 expression. 
Results 
Disc tissues from internal derangements (both ADDwR and ADDwoR) exhibited a much higher percentage of 
TRAIL- and DR5-positive cells as well as stain intensity compared with normal tissue though with regional 
variation according to the portion of the disc. There was a significantly higher percentage of stained cells in the 
posterior disc attachment compared with the anterior or intermediate bands of both ADDwR and ADDwoR discs 
for TRAIL and DR5. 
Conclusions 
TRAIL and DR5 are overexpressed in displaced human TMJ disc, especially in the posterior disc attachment. 
These results suggest a possible pivotal role of the TRAIL/DR5 system in TMJ disc degeneration. 
 
Internal derangements (IDs) are among the most frequent causes of temporomandibular joint (TMJ) 
disease.1, 2, 3 They represent a disturbance in the normal anatomic relationship between the intra-articular disc 
and the condyle, resulting in an interference with the smooth movement of the joint. If the disc slips out of place 
or is displaced, it can prevent the proper movement of the condyle and cause dysfunction. There are 2 common 
types of internal derangements. The more frequently seen is an anterior disc displacement with reduction 
(ADDwR), when the disc slides in and out of its normal functional position as the jaw opens or closes, causing a 
popping sound. In the case of anterior disc displacement without reduction (ADDwoR), the disc is permanently 
displaced or dislocated, and the jaw's range of motion is limited.2, 4 In these instances, it has been speculated 
that TMJ disc tissue is damaged directly or indirectly by excessive mechanical stress and the disc, in most of 
these cases, becomes deformed, misshapen, or even torn.5, 6, 7 Progress made using cellular and molecular 
biology techniques has led to increased understanding in the pathogenesis and mechanisms of disc 
degeneration. However, as far as TMJ disc is concerned, studies have dealt mostly with collagen breakdown and 
cytokine overexpression.8, 9, 10, 11 These studies have shown that degenerative joint changes are due largely to an 
imbalance between matrix tissue synthesis and degeneration, probably caused by apoptosis. 
 
In the other joints, nonphysiologic mechanical loading induces disc degeneration through an apoptotic-related 
process that leads to a diminished generation, organization, and repair of the extracellular matrix. Apoptosis is a 
physiologic process implicated in various aspects of mammalian development, including embryogenesis, normal 
tissue turnover, and homeostasis. FasL, tumor necrosis factor (TNF) α, and TNF-related apoptosis-inducing ligand 
(TRAIL) are common apoptosis-induced factors, known to trigger apoptosis through distinct signal pathways.12, 13 
Recently, a major role of TRAIL and its death receptors (DRs) has been observed in some studies regarding 
intervertebral disc (IVD) degeneration.14, 15 TRAIL is an apoptosis-inducing member of the TNF gene family which 
cross-links 3 receptor molecules on the surface of target cells. To date, 5 human TRAIL receptors have been 
identified: DR4/TRAIL-R1, DR5/TRAIL-R2/TRICK2, TRID/DcR1/TRAIL-R3, TRAIL-R4/DcR2, and osteoprotegerin 
TRAIL which triggers apoptotic signals through interaction with DR4 and DR5.16, 17, 18, 19, 20 
 
In TMJ disc tissue, one study demonstrated that TRAIL was overexpressed in apoptotic chondrocyte-like 
cells.21 However, it remains unclear how TRAIL and its receptor DR5 are involved in TMJ IDs (with and without 
disc reduction) and where they are regionally distributed in damaged TMJ disc cells. Therefore, the present 
investigation was designed to examine, through immunohistochemistry, the regional expression of TRAIL and 
DR5 in TMJ discs of ADDwR and ADDwoR patients to better understand the relationship between TMJ disc 
displacement and apoptosis. 
Materials and Methods 
Patients and tissues 
Eighteen TMJ displaced disc specimens were collected from consecutive patients treated between 2002 and 
2008 at the Pontifical Catholic University of Paraná, Curitiba, Brazil. Four virtually unaffected human TMJ discs, 
selected from the archives of the Anatomy Institute of Catania University, Italy, were studied along with the 
pathologic material. After project approval by the ethics committee of the same university, informed consent 
was obtained from each patient before tissue collection. 
 
The discs (10 from the right TMJ and 8 from the left) were obtained from 14 female and 4 male patients affected 
by temporomandibular joint IDs (11 patients were affected by ADDwR and 7 by ADDwoR), as confirmed by their 
clinical history, examination, and magnetic resonance imaging studies (Fig. 1). The mean age of all patients was 
34.2 ± 5.4 years (ranging from 24 to 41 years). Clinical characteristics, mean ages, SD, median, and duration of ID 
before surgery for ADDwR and ADDwoR, were divided into 2 groups according to type of ID. Patients affected by 
ADDwR had a mean age of 32.7 ± 5.5 years (range 24-41 years), and those with ADDwoR had a mean age 36.5 ± 
4.4 years (range 28-41 years). The duration of ID before surgery was 8.9 ± 1.3 months (range 7-10 months) for 
ADDwR patients and 8.1 ± 06 (range 7-9 months) for ADDwoR patients. Nine patients were caucasian, 6 native 
American, and 3 African Brazilian. The diagnosis that led to surgery was disc derangement with associated pain 
and impairment of function. Inclusion criteria were: 1) unsuccessful nonsurgical treatment before surgery; 2) 
diagnosis of internal derangement of the TMJ; and 3) TMJ pain or interference with mandibular movements. 
Exclusion criteria were: 1) other TMJ diseases; 2) dentofacial deformity; 3) major jaw trauma; 4) previous TMJ 
surgery; and 5) previous steroid injections in the TMJ. 
 
 
Fig. 1. Magnetic resonance image of a temporomandibular joint disc displacement (arrow) in closed mouth of a patient with 
anterior disc displacement with reduction. The posterior band appears thinned. 
 
All patients' discs surgically removed were macroscopically deformed; none of the discs had a normal biconcave 
shape. Both patient and autopsy specimens included the anterior band, intermediate band, and the posterior 
disc attachments. 
 
The 4 autopsy TMJ disc specimens that had been embedded in paraffin were obtained from 1 male and 3 female 
subjects (mean age 49.7 ± 4.4 years) from the Anatomy Institute of Catania University, Italy. These were selected 
because: 1) the subjects' clinical history gave no indication of generalized joint diseases or TMJ arthropathy; 2) 
macroscopic signs of degenerative or inflammatory joint disease were not evident upon dissection; and 3) 
microscopic examination of sections stained with Harry hematoxylin revealed no pathologic changes. 
 
Immunohistochemistry 
The discs were fixed overnight in 10% neutral buffered formalin (Bio-Optica, Milan, Italy). After fixation and 
overnight washing, each disc was sectioned through its center along a parasagittal plane, perpendicular to its 
long axis. Each tissue block was dehydrated in graded ethanol and embedded in paraffin, preserving the 
longitudinal anatomic orientation. Specimens were sectioned (5 μm) and placed on silanized glass slides with the 
anterior band always oriented to the right, for routine hematoxylin staining and subsequent 
immunohistochemistry. The sections were irradiated (5 minutes × 3) in capped polypropylene slide holders with 
citrate buffer (pH 6), using a microwave oven (750 W) to unmask antigenic sites. 
 
Rabbit polyclonal anti-TRAIL (Santa Cruz Biotechnology, Santa Cruz, CA) and anti-DR5 (Novus Biologicals, LLC, 
Littleton, CO) were used at 1:20 working dilution. Each antibody was applied and sections incubated overnight at 
4°C in a humidified chamber. Immunocomplexes were subsequently detected with secondary antibody and then 
with streptavidin-peroxidase complexes for 15 minutes each at room temperature (LSAB2/HRP kit; Dako, 
Denmark, A/S Produktionsvej, Glostrup, Denmark). After rinsing with phosphate-buffered saline, sections were 
exposed to 0.1% 3,3′-diaminobenzidine and 0.02% hydrogen peroxide solution (DAB substrate kit; Vector 
Laboratories, Burlingame, CA) for 4 minutes. Sections were lightly counterstained with Meyer hematoxylin. 
 
Evaluation of immunohistochemistry 
All slides were coded and evaluated without knowledge of the patient's identity, clinical status, and group 
identification (blinded). Immunostained sections were examined with a light microscopy. Two of the authors 
(R.L. and C.L.), each with ≥10 years' experience in immunohistochemistry techniques and TMJ disc tissue 
microscopic evaluation, performed the assessment of the TMJ disc immunostained sections on a mutual 
consensus basis, using a double-headed microscope. 
 
Stain intensity and the proportion of immunopositive cells were examined by light microscopy and recorded for 
both TRAIL and DR5 antibodies. Three different TMJ disc tissue compartments were analyzed: the anterior band 
(AB), intermediate band (IB), and the posterior disc attachment (PDA). Intensity of staining was graded on a 
scale of 0-4, according to the following assessment: 0 = no detectable staining; 1 = weak staining; 2 = moderate 
staining; 3 = strong staining; 4 = very strong staining. The percentage of TRAIL and DR5 immunopositive cells 
(extent score [ES]) were also independently evaluated and scored as a percentage of the final number of the 200 
cells in 4 categories: 0 = ≤5%; 1 = 6%-30%; 2 = 31%-50%; 3 = ≥51%; 4 = >75%. Counting was performed at ×200 
magnification. The final staining score (FSS) was derived from the sum of the intensity score and the ES. 
 
Positive and negative control 
Positive and negative controls were performed to test the specific reaction of primary antibodies used in this 
study. For positive control testing, sections from gastric cancer tissue were immunohistochemically 
analyzed.22 Strong positive immunolabeling for TRAIL and DR5 was both membranous and cytoplasmic in these 
sections. For negative control testing, sections of TMJ displaced discs were randomly drawn from ADDwoR and 
ADDwR samples. These were then treated with normal rabbit serum instead of the specific antibodies. 
 
Statistical analysis 
The data were analyzed using Mann-Whitney U tests. P values of <.05 were considered to be statistically 
significant. The Mann-Whitney U test was used to compare protein expression (TRAIL and DR5) as an FSS among 
disc specimens. Comparisons were made based on the anatomic region of the disc of the specimens of patients 
affected by ADDwR or ADDwoR. All data were analyzed with the SPSS program (release 16.0; SPSS, Chicago, IL). 
Results 
All TMJ patients had been unsuccessfully treated with other various interventions for at least 6 months before 
surgery. Diseased TMJ disc sections, stained with hematoxylin (routine staining) showed a different severity of 
morphologic damage, ranging from an altered collagen bundle architecture to fragmentation of the collagen 
bundles. A change in cell population ratios was also observed. Chondrocyte-like cells increased in prevalence in 
the severely damaged discs, whereas fibroblast-like cells decreased. However, all in all, a decrease in cellularity 
was noted in the more damaged discs. In contrast, the control discs showed preservation of multidirectional 
collagen bundles, predominately fibrocyte-like cell populations with few chondrocyte-like cell aggregates, and 
absence of clefts and/or fraying. 
 
Immunohistochemical reactivity for TRAIL was detected in the cytoplasm of the TMJ disc cells, and the 
expression of DR5 was recognized in the cell membrane and cytoplasm. Immunolabeling for TRAIL and DR5 was 
found in all of the disc sections, but they were expressed in most of the samples with different patterns of 
reactivity according to the topography and kind of disc displacement. Disc tissues from ID (both ADDwR and 
ADDwoR) exhibited a much higher percentage of TRAIL- and DR5-positive cells, as well as stain intensity, than 
the normal tissue, though with regional variation according to the portion of the disc. The FSS was consistently 
higher for ADDwoR than ADDwR in every portion of the disc, for the sections stained both with TRAIL and with 
DR5 antibodies. 
 
Table I presents TRAIL and DR5 mean FSS for each portion of the disc (AB, IB, and PDA) and type of ID (ADDwR 
and ADDwoR). Table II shows TRAIL and DR5 the mean number of stained cells or ES in each region of the disc. 
Posterior disc attachment (Fig. 2) showed a higher FSS and ES for TRAIL and DR5 both in ADDwR and in ADDwoR 
discs than the other 2 bands (Fig. 3). Also, the mean number of stained cells (ES) was higher in the PDA than the 
other 2 regions of the disc both for TRAIL in ADDwR and ADDwoR and for DR5 in ADDwoR. Almost all disc cells of 
the PDA were strongly immunolabeled by TRAIL antibody both in ADDwR and in ADDwoR discs (Fig. 2). In 
contrast, the IB demonstrated a moderate to strong staining pattern in some cells (Fig. 3). Highly significant 
differences (P < .001) were obtained when comparing TRAIL FSS between PDA, IB, and AB both for ADDwR and 
ADDwoR (Table I). PDA showed the highest TRAIL FSS, AB the lowest, and IB a middle value, both for ADDwR and 
for ADDwoR discs. The DR5 FSS values were generally lower than TRAIL except for the PDA in the ADDwoR 
(Table I). A moderate to strong staining pattern for DR5 was observed in the disc cells of most cases, PDA 
showed a higher DR5 FSS than the other 2 portions of the disc, especially in ADDwoR discs (Fig 4). When 
comparing each portion of the disc with the others, TRAIL showed statistically significant differences both for 
ADDwR and for ADDwoR. However, for DR5, only ADDwoR showed significant differences when comparing the 3 
areas of the disc, whereas ADDwR did not (Table II). 
 
Table I. Final staining score in temporomandibular joint disc of patients with internal derangment (ID). Final 
staining score (sum of stain intensity and extent score) mean value, standard deviation (SD), median, and 
standard error (SE) for tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) and its receptor DR5 
immunolabeling according to the type of ID  
Mean SD Median SE 
TRAIL 
    
 ADDwR 
    
  AB 3 0.77 3 0.23 
  IB 4 1.18 2 0.35 
  PDA 6 0.89 5 0.26 
 ADDwoR 
    
  AB 4 0.81 3 0.30 
  IB 5 0.81 4 0.30 
  PDA 7 0.81 6 0.30 
DR5 
    
 ADDwR 
    
  AB 3 0.77 3 0.23 
  IB 3 1.00 3 0.30 
  PDA 4 1.09 4 0.33 
 ADDwoR 
    
  AB 3 0.81 3 0.30 
  IB 4 0.81 4 0.30 
  PDA 6 1.15 6 0.43 
ADDwR, Anterior disc displacement with reduction; ADDwoR, anterior disc displacement without reduction; AB, 
anterior band; IB, intermediate band; PDA, posterior disc attachment. 
 
Table II. Extent score in temporomandibular joint disc of patients with internal derangment (ID). Extent score 
(percentage of immunopositive cells) mean value, standard deviation (SD), median, and standard error (SE), for 
tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) and its receptor DR5 immunolabeling according 
to the type of ID  
Descriptive statistic    Mann-Whitney U test   




      
 ADDwR 
      
  AB 35.9 4.8 28 1.44 AB vs. IB ⁎
 
  IB 52.2 5.6 47 1.71 IB vs. PDA ⁎⁎⁎
 
  PDA 70.8 5.1 64 1.56 PDA vs. AB ⁎⁎⁎
 
 ADDwoR 
      
  AB 54.1 6.36 44 2.40 AB vs. IB ⁎
 
  IB 55.1 5.52 48 2.08 IB vs. PDA ⁎⁎⁎
 
  PDA 78.1 2.85 73 1.07 PDA vs. ⁎⁎⁎
 
DR5 
      
 ADDwR 
      
  AB 36.7 4.14 29 1.25 AB vs. IB NS 
  IB 34.3 2.20 31 0.66 IB vs. PDA NS 
  PDA 40.4 3.36 36 1.01 PDA vs. AB NS 
 ADDwoR 
      
  AB 39.2 4.30 33 1.62 AB vs. IB ⁎
 
  IB 38.8 3.28 35 1.24 IB vs. PDA ⁎
 
  PDA 61.5 5.96 55 2.25 PDA vs. AB ⁎⁎⁎
 
Abbreviations as in Table I. 
P values obtained by Mann-Whitney U test on TRAIL and DR5 expressions when comparing the 2 different types 
of IDs (ADDwR and ADDwoR, respectively) between regions (AB, IB, and PDA): 
**P < .01; 
⁎P < .05; 
⁎⁎⁎P < .001; NS, not significant. 
 
 
Fig. 2. Immunostaining for tumor necrosis factor–related apoptosis-inducing ligand in the posterior disc 
attachment. Microphotographs from temporomandibular joint disc of patients affected by disc displacement 
without reduction (a) and with reduction (c). (b) Magnification of the box of in a. (d) Magnification of the box in 
c. Arrow = fibroblast; doubleheaded arrow = immunonegative staining. Bar = 100 μm. 
 
 
Fig. 3. Immunostaining for tumor necrosis factor–related apoptosis-inducing ligand in the intermediate band of 
the disc. Microphotographs from temporomandibular joint disc of patients affected by disc displacement 
without reduction (a) and with reduction (c). (b) Magnification of the box of in a. (d) Magnification of the box in 




Fig. 4. Immunostaining for death receptor 5 in the intermediate band of the disc. Microphotographs from 
temporomandibular joint disc of patients affected by disc displacement with reduction. Arrow = fibroblast; open 
arrow = fibrochondrocyte. Bar = 100 μm. 
 
In control discs, few scattered cells were immunolabeled by TRAIL and DR5. Significant differences between the 
3 regions of the disc were not seen in these normal disc specimens (P > .05). Although the immunoreaction 
products for TRAIL and DR5 were few, they were detected in all cell populations (i.e., fibroblast-like cells, 
fibrochondrocytes, and chondrocyte-like cells) in the PDA, and in chondrocyte-like cells and fibroblast-like cells 
in the AB and IB. 
 
Discussion 
There appears to be a wide consensus regarding the relationship between TMJ disc position and disc 
degeneration.23, 24, 25, 26, 27 It seems that these degenerative changes, just as with other joints, are influenced by 
the type and degree of disc displacement. The more advanced the internal derangement, the more deteriorated 
the disc configuration will be.28 However, to date molecular events that lead to TMJ disc degeneration are still 
unclear, at least regarding cellularity loss. A series of chemical mediators and cytokines have been reported to 
play a major role in various TMJ degenerative changes. Among these, TNF-α, a cytokine closely related to TRAIL, 
has been detected in the synovial fluid and tissue of patients with IDs and has been correlated with 
osteoarthrosis, synovial inflammation, and pain leading to an unsuccessful clinical outcome after TMJ 
irrigation.29, 30, 31, 32, 33, 34, 35, 36, 37, 38 Its expression has also been related to apoptosis of chondrocytes in the 
mandibular condyle. Not withstanding these studies and the fact that TNF-α represents one of the 3 major 
apoptosis-inducing factors, no study has extensively addressed its implication in TMJ disc cell apoptosis. 
 
In other joints, such as intervertebral disc (IVD), tissue apoptotic cell death has been suggested as being a major 
contributing factor of herniated disc tissue degeneration because apoptosis increased with the severity of disc 
pathologic findings.12, 15, 39, 40, 41 Moreover, evidence of a dose-dependent relationship between apoptosis and 
nonphysiologic mechanical loading in herniated IVD has been provided. Some investigations have shown that 
the highest amount of cell death in IVD is observed in those areas mostly affected by disc deformation.14, 42 Thus, 
results from these studies suggest a pivotal role for disc displacement leading to induction of cell apoptosis and 
extracellular matrix degradation, which can lead to IVD degeneration.12, 41 
 
Among the 3 major apoptosis-inducing factors that are known to trigger apoptosis through distinct signal 
pathways, TRAIL and its receptors have gained interest recently in IVD degeneration. Zhang et al.43 reported a 
stronger expression of DR4 (one of the TRAIL receptors) in all samples of degenerative herniated discs versus 
normal discs. In addition, DR4 expression at various stages of disc herniation was positively correlated with the 
degeneration progress. Bertram et al.14 argued that protein and gene expression of TRAIL and the death 
receptors DR4 and DR5 correlate with the progression of degeneration in human intervertebral discs.14, 15 
According to their findings, the authors argued that disc cells inherit the molecular machinery to induce IVD 
apoptosis, and TRAIL/DR4/DR5 axis is an important molecular mediator of apoptosis induction in disc tissue.14 
 
Findings from the present study demonstrate that TRAIL, a member of the TNF family, and its receptor DR5 are 
overexpressed in excised displaced TMJ discs. These overexpressions increase with the type of disc displacement 
and show regional variation, in that the bilaminar zone represents the area with a higher final staining score. 
Furthermore, the present results show that TRAIL and DR5 expression dramatically change in displaced human 
TMJ disc, in that the prevalence of immunopositive cells increase in the following order: normal, ADDwR, and 
ADDwoR. Moreover, regional variation in the zones of the disc was appreciated, as there was a higher up-
regulation in the pPDA at least regarding TRAIL. 
 
Interestingly, these results support earlier imaging findings on TMJ disc degeneration that argue that disc 
degeneration starts from the posterior portion of the disc.44, 45 In magnetic resonance imaging studies that 
investigated the signal intensities (SI) of TMJ displaced discs, the SI of the posterior bands were found to be 
higher than those of the ABs and increased with the progress of internal derangement. Thus, data are 
accumulating that disc degeneration begins in the posterior band of the disc.44 Consistent with this, we found 
significantly higher FSS grading in the PDA, suggesting that, in this area, there are more cells undergoing 
apoptosis and, presumably this is an area that shows initial degenerative changes. 
 
To our knowledge, this is the first study to address the question of a zonal distribution of TRAIL and DR5 within 
displaced TMJ discs as well as correlating these findings with the different kinds of ID. All in all, this study 
provides new insights relevant to the presence and distribution of apoptosis in TMJ displaced discs. The 
observed correlation of TRAIL/DR5 expression with increased severity of TMJ disc displacement suggests a 
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